Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study

1 Jun 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Metabolomics and Mass Spectrometry Studies
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31183578
DOI: 10.1007/s11306-019-1554-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot studyPMID 31183578Read ↗

Levodopa and dopamine dynamics in Parkinson’s disease metabolomicsSemantic proximity Read ↗

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity Read ↗

Untargeted <sup>1</sup> H NMR-based metabolomics reveal sex-based differences in blood metabolome profiles among patients with Parkinson’s disease, regardless of their idiopathic or genetic subtypeSemantic proximity Read ↗

The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and<i>PRKN/PINK1</i>-mediated Parkinson’s disease – a large-scale targeted metabolomics studySemantic proximity Read ↗

Biomarker Research in Parkinson’s Disease Using Metabolite ProfilingSemantic proximity Read ↗

Metabolomics of blood reveals age-dependent pathways in Parkinson’s DiseaseSemantic proximity Read ↗

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.Semantic proximity Read ↗

Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity Read ↗

Sex differences impact serum metabolome profiles in patients with familial Parkinson’s diseaseSemantic proximity Read ↗

Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenuesSemantic proximity Read ↗

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Semantic proximity Read ↗

Discovery of Sexual Dimorphism in the Serum Metabolome of Parkinson’s Disease Patients Harboring Rare Genetic Variants with Uncertain PathogenicitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.